Zimmer Biomet CEO exercises RSUs, pays taxes in stock

Zimmer Biomet Holdings Chairman, President and CEO Ivan Tornos exercised restricted stock units into 34,704 shares of common stock on March 6, 2026.

Rhea-AI Filing Summary

Zimmer Biomet Holdings Chairman, President and CEO Ivan Tornos exercised restricted stock units into 34,704 shares of common stock on March 6, 2026. The company withheld 19,195 shares at $92.54 per share to cover tax obligations, leaving him with 83,191 shares held directly.

Insider Trade Summary

34,704 shares exercised/converted

Exercise 9 txns

Insider Tornos Ivan

Role Chairman, President and CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	24,436	$0.00	$0.00
Exercise	Restricted Stock Units	4,830	$0.00	$0.00
Exercise	Restricted Stock Units	5,438	$0.00	$0.00
Exercise	Common Stock	24,436	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	13,516	$92.54	$1.25M
Exercise	Common Stock	4,830	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,671	$92.54	$247K
Exercise	Common Stock	5,438	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,008	$92.54	$278K

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 83,191 shares (Direct)

Footnotes (2)

1. F1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
2. F2. Each RSU represents a contingent right to receive one share of Company common stock.

FAQ

What insider transaction did Zimmer Biomet (ZBH) CEO Ivan Tornos report?

Ivan Tornos exercised restricted stock units into 34,704 shares of Zimmer Biomet common stock. These transactions on March 6, 2026 reflect RSU vesting and option-style conversions rather than open-market buying, providing him additional directly held equity in the company.

How many Zimmer Biomet (ZBH) shares were withheld for Ivan Tornos’ taxes?

Zimmer Biomet withheld 19,195 shares from Ivan Tornos to satisfy tax obligations tied to RSU vesting. These F-code transactions occurred at a reference price of $92.54 per share and are classified as tax-withholding dispositions, not open-market sales by the executive.

How many Zimmer Biomet (ZBH) shares does Ivan Tornos hold after this Form 4?

After the March 6, 2026 transactions, Ivan Tornos directly owns 83,191 Zimmer Biomet common shares. This figure reflects RSU conversions into stock and shares withheld for taxes, as shown by the total shares following the final reported non-derivative transaction.

Were Ivan Tornos’ Zimmer Biomet (ZBH) Form 4 transactions open-market sales?

No, the Form 4 shows no open-market sales by Ivan Tornos. Dispositions are F-code entries, meaning Zimmer Biomet withheld shares at $92.54 each to pay tax liabilities from RSU vesting, a routine administrative action rather than discretionary selling.

What types of securities did Zimmer Biomet (ZBH) CEO Ivan Tornos convert?

Ivan Tornos converted restricted stock units, which are derivative securities, into Zimmer Biomet common stock. Each RSU represented a contingent right to receive one share of common stock, and all RSU positions reported in this filing were exercised on March 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tornos Ivan

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		24,436	A	$0	92,118	D
Common Stock	03/06/2026		F		13,516(1)	D	$92.54	78,602	D
Common Stock	03/06/2026		M		4,830	A	$0	83,432	D
Common Stock	03/06/2026		F		2,671(1)	D	$92.54	80,761	D
Common Stock	03/06/2026		M		5,438	A	$0	86,199	D
Common Stock	03/06/2026		F		3,008(1)	D	$92.54	83,191	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/06/2026		M			24,436	03/06/2026	03/06/2026	Common Stock	24,436	$0	0	D
Restricted Stock Units	(2)	03/06/2026		M			4,830	03/06/2026	03/06/2026	Common Stock	4,830	$0	0	D
Restricted Stock Units	(2)	03/06/2026		M			5,438	03/06/2026	03/06/2026	Common Stock	5,438	$0	0	D

Explanation of Responses:

1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

2. Each RSU represents a contingent right to receive one share of Company common stock.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed)	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.